相关实验视频

Updated: Jul 24, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

富可丁通过调节Ran表达来抑制胃癌淋巴血管生成和转移

Jia Wang¹, Xue Dong², Dandan Li²

¹Stem Cell Clinical Research Center, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China; Department of Critical Care Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116021, China.

Phytomedicine : international journal of phytotherapy and phytopharmacology

|July 1, 2023

概括

富可丁通过准Ran蛋白来抑制胃癌淋巴结转移. 这种天然化合物通过importinβ/NF-κB/VEGF-C通路抑制淋巴血管生成和转移,提供了潜在的新治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

淋巴结转移对于胃癌 (GC) 的进展至关重要.
淋巴细胞生成是GC淋巴结转移的一个关键步骤.
目前没有任何药物专门针对GC淋巴结转移;富可桑对其影响尚未研究.

研究的目的:

为了研究富可桑丁对淋巴血管生成和胃癌转移的作用.
阐明富可桑作用的基础分子机制.
探索富可桑丁作为一种潜在的治疗药物,用于GC淋巴结转移.

主要方法:

细胞计数套件8,穿孔测定和共同培养系统,以评估扩散,迁移和入侵.
在体内脚转移模型来评估淋巴细胞形成和淋巴结转移.
组织微阵列,生物信息学,分子对接,共聚焦显微镜和西部抹迹来识别目标和途径.

主要成果:

兰在转移的GC淋巴结中表达很高,并预测了转移.
富可丁与Ran.Ran直接发生相互作用.
富可丁通过降低Ran和importinβ的调节来抑制NF-κB的核运输,抑制VEGF-C分泌,从而抑制瘤淋巴血管生成和转移.

结论:

富可丁通过importinβ/NF-κB/VEGF-C通路调节Ran表达来抑制GC淋巴血管生成和转移.
这些发现支持fucoxanthin作为GC淋巴结转移的新疗法潜力.
这项研究对基于传统中医药的癌症治疗具有重要的理论和临床价值.

关键词:

富可桑胺是一种富可桑胺.胃癌胃癌是指胃癌.淋巴细胞生成 (Lymphangiogenesis) 是一种发生淋巴细胞的过程.转移转移转移转移分子对接是分子对接.跑跑跑,跑跑,跑跑,跑跑.

更多相关视频

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...